Annemarie Sykes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annemarie Sykes has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian L. Johnston
National Heart and Lung Institute, Imperial College London London UK
3 shared publications Ajerico del Rosario
National Heart & Lung Institute, Imperial College London, London, United Kingdom
2 shared publicationsJonathan Macintyre
National Heart & Lung Institute, Imperial College London, London, United Kingdom
2 shared publicationsMark McHale
Respiratory and Inflammation Research Area, AstraZeneca R&D Charnwood, Loughborough, United Kingdom
2 shared publications- Michael R. Edwards
Imperial College London
2 shared publications - Onn Min Kon
Chest and Allergy Clinic, Imperial College Healthcare NHS Trust, London, UK
2 shared publications
Latest Publications
- 30 June 2013
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 42 (1) , 285-287
Inhalational anthrax in a vaccinated soldier
- 30 June 2013
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 42 (1) , 285-287
Inhalational anthrax in a vaccinated soldier
- Open Access
- 18 June 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e65921
TLR3, TLR4 and TLRs7–9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma
Defective Rhinovirus induced interferon-β and interferon-λ production has been reported in bronchial epithelial cells from asthmatics but the mechanisms of defective interferon induction in asthma are unknown. Virus infection can induce interferon through Toll like Receptors (TLR)3, TLR7 and TLR8. The role of these TLRs in interferon induction in asthma is unclear. This objective of this study was to measure the type I and III interferon response to TLR in bronchial epithelial cells and peripheral blood cells from atopic asthmatics and non-atopic non-asthmatics. Bronchial epithelial cells and peripheral blood mononuclear cells from atopic asthmatic and non-atopic non-asthmatic subjects were stimulated with agonists to TLR3, TLR4 & TLRs7–9 and type I and III interferon and pro-inflammatory cytokine, interleukin(IL)-6 and IL-8, responses assessed. mRNA expression was analysed by qPCR. Interferon proteins were analysed by ELISA. Pro-inflammatory cytokines were induced by each TLR ligand in both cell types. Ligands to TLR3 and TLR7/8, but not other TLRs, induced interferon-β and interferon-λ in bronchial epithelial cells. The ligand to TLR7/8, but not those to other TLRs, induced only type I interferons in peripheral blood mononuclear cells. No difference was observed in TLR induced interferon or pro-inflammatory cytokine production between asthmatic and non-asthmatic subjects from either cell type. TLR3 and TLR7/8,, stimulation induced interferon in bronchial epithelial cells and peripheral blood mononuclear cells. Interferon induction to TLR agonists was not observed to be different in asthmatics and non-asthmatics.
- 18 June 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e65921
Open AccessTLR3, TLR4 and TLRs7–9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma
Defective Rhinovirus induced interferon-β and interferon-λ production has been reported in bronchial epithelial cells from asthmatics but the mechanisms of defective interferon induction in asthma are unknown. Virus infection can induce interferon through Toll like Receptors (TLR)3, TLR7 and TLR8. The role of these TLRs in interferon induction in asthma is unclear. This objective of this study was to measure the type I and III interferon response to TLR in bronchial epithelial cells and peripheral blood cells from atopic asthmatics and non-atopic non-asthmatics. Bronchial epithelial cells and peripheral blood mononuclear cells from atopic asthmatic and non-atopic non-asthmatic subjects were stimulated with agonists to TLR3, TLR4 & TLRs7–9 and type I and III interferon and pro-inflammatory cytokine, interleukin(IL)-6 and IL-8, responses assessed. mRNA expression was analysed by qPCR. Interferon proteins were analysed by ELISA. Pro-inflammatory cytokines were induced by each TLR ligand in both cell types. Ligands to TLR3 and TLR7/8, but not other TLRs, induced interferon-β and interferon-λ in bronchial epithelial cells. The ligand to TLR7/8, but not those to other TLRs, induced only type I interferons in peripheral blood mononuclear cells. No difference was observed in TLR induced interferon or pro-inflammatory cytokine production between asthmatic and non-asthmatic subjects from either cell type. TLR3 and TLR7/8,, stimulation induced interferon in bronchial epithelial cells and peripheral blood mononuclear cells. Interferon induction to TLR agonists was not observed to be different in asthmatics and non-asthmatics.
- 1 March 2013
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 20 (2) , 56-60
Asthma and Infections
Asthma is common, affecting approximately 300 million people of all ages globally and the incidence is increasing in many countries. Although stable asthma is a problem, the majority of mortality morbidity and health care expenditure is associated with asthma exacerbations. The majority of asthma exacerbations are related to respiratory virus infections, particularly rhinovirus, and asthmatic airways may have a defective interferon response to rhinovirus infection. This review summarizes the current literature on the role of viruses, evidence for defective interferon induction in asthma, and suggests a potential role for bacteria in asthma exacerbations.
- 1 March 2013
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 20 (2) , 56-60
Asthma and Infections
Asthma is common, affecting approximately 300 million people of all ages globally and the incidence is increasing in many countries. Although stable asthma is a problem, the majority of mortality morbidity and health care expenditure is associated with asthma exacerbations. The majority of asthma exacerbations are related to respiratory virus infections, particularly rhinovirus, and asthmatic airways may have a defective interferon response to rhinovirus infection. This review summarizes the current literature on the role of viruses, evidence for defective interferon induction in asthma, and suggests a potential role for bacteria in asthma exacerbations.
- 1 June 2012
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 129 (6) , 1506-1514.e6
Rhinovirus 16–induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients
- 1 June 2012
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 129 (6) , 1506-1514.e6
Rhinovirus 16–induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients
- 1 October 2008
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 122 (4) , 685-688
Etiology of asthma exacerbations
- 1 October 2008
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 122 (4) , 685-688
Etiology of asthma exacerbations